Evanson Asset Management, LLC Corbus Pharmaceuticals Holdings, Inc. Transaction History

Evanson Asset Management, LLC

  • $1.35 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

Apr 24, 2020
SELL
$3.44 - $7.21 $68,800 - $144,200
-20,000 Closed
0 $0
Q3 2019

Oct 11, 2019
SELL
$4.87 - $7.08 $3,798 - $5,522
-780 Reduced 3.75%
20,000 $97,000
Q2 2019

Jul 11, 2019
BUY
$6.6 - $7.8 $3,168 - $3,744
480 Added 2.36%
20,780 $144,000
Q3 2017

Nov 14, 2017
BUY
$5.75 - $7.75 $116,725 - $157,325
20,300
20,300 $145,000

Others Institutions Holding CRBP

# of Institutions
4
Shares Held
38.7K
Call Options Held
0
Put Options Held
0
View Full List

About Corbus Pharmaceuticals Holdings, Inc.

CRBP Quotes by TradingView
  • Ticker CRBP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 125,268,000
  • Market Cap $1.5B
  • Description
  • Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...
More about CRBP
Track This Portfolio

Track Evanson Asset Management, LLC Portfolio

Follow Evanson Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Evanson Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Evanson Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email